Statement 3.3

Section 3

"Before making a pharmacy preparation, the hospital pharmacist must undertake a risk assessment to determine the best practice quality requirements. These must consider premises, equipment, pharmaceutical knowledge and labelling."

What does it mean for patients? If the risk/benefit assessment is positive the pharmacist should decide about the necessary level of interventions necessary to optimize the quality of the produced medicine. Unambiguous and complete labelling is paramount to avoid any confusion, misinterpretation or administration error in the whole process. 

What does it mean for healthcare professionals? Doctors and nurses should rely on the pharmacist as the expert in deciding about the necessary level of interventions necessary to optimize the quality of the produced medicine. Unambiguous and complete labelling is paramount to avoid any confusion, misinterpretation or administration error in the whole process. 

What does it mean for Hospital Pharmacists? Patients have the right to get the best quality of medicines independently from industrial production or individual preparation.
Hospital pharmacists should guarantee that 

  • The facilities of the pharmacy are adequate 

  • The personnel is trained 

  • The production procedure is 
defined and validated 

  • The quality of all starting 
materials is appropriate 

  • The packaging material is appropriate and compatible to the product 

  • The labelling is unambiguous, complete and based on principle of f safe administration 

 

 

Premises, facilities and pharmaceutical knowledge should be appropriate for the preparation of the medicinal product and correct labelling should be assured through the whole process from production to administration. 

 

Resources

Preview Title Document
EAHP Brochure PDF icon Attachment 6-EAHP Brochure-GA.pdf

Pages